Calmafusion 380mg/60mg/50mg 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

calmafusion 380mg/60mg/50mg

interchemie werken de adelaar eesti as, vanapere tee 14, püünsi, općina viimsi, okrug harju 74013, estonija - kalcijev glukonat za injekciju; magnezijev klorid heksahidrat ; boratna kiselina; - otopina za infuziju, za goveda, ovce i svinje - kalcij, kombinacije s vitaminom d i/ili drugim lijekovima - goveda, ovaca, svinja

Calcibel, 240/60/60 mg/mL 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

calcibel, 240/60/60 mg/ml

bela-pharm gmbh & co. kg, lohner strasse 19, 49377 vechta, njemačka - kalcijev glukonat ; magnezijev klorid heksahidrat ; boratna kiselina - otopina za infuziju, za konje, goveda, ovce, koze i svinje - konja, goveda, ovaca, koza, svinja

Addimag, 160 mg/mL + 84 mg/mL 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

addimag, 160 mg/ml + 84 mg/ml

alfasan nederland b.v., kuipersweg 9, 3449 ja woerden, nizozemska - kalcijev glukonat; magnezijev klorid heksahidrat - otopina za infuziju - goveda

Addimag, 240 mg/mL + 126 mg/mL 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

addimag, 240 mg/ml + 126 mg/ml

alfasan nederland b.v., kuipersweg 9, 3449 ja woerden, nizozemska - kalcijev glukonat; magnezijev klorid heksahidrat - otopina za infuziju - goveda

CALCIO-CALIER FORTE 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

calcio-calier forte

vet consulting d.o.o., matije gupca 42, 43500 daruvar, hrvatska - kalcijev boroglukonat magnezijev klorid heksahidrat magnezijev hipofosfit heksahidrat - injekcijska otopina - goveda

BiResp Spiromax 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Vylaer Spiromax 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

vylaer spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - vylaer spiromax je indiciran u odrasloj dobi od 18 i više godina. asthmavylaer spiromax drugačije u redovnom liječenju astme, gdje je upotreba kombinacije (inhalacijskim kortikosteroidima i trajno djeluju β2 адренорецепторов) prikladno:u bolesnika adekvatno ne prati ингаляционными kortikosteroidima i "po potrebi" udahnuti короткодействующих β2 адреномиметиков. Орин pacijenata već adekvatno prati na oba inhalacijskim kortikosteroidima i trajno djeluju β2 адреномиметиков. copdsymptomatic liječenje bolesnika s teškim kopb (ОФВ1 < 50%, predviđa normalno) i ponovljenim vrhunac, koji imaju značajne simptome, unatoč regularnu terapiju s длинн-djeluje bronhodilatatora.